<DOC>
	<DOC>NCT00219570</DOC>
	<brief_summary>To investigate, in a comparison vs. Acuatim cream (nadifloxacin cream), the efficacy and safety of Dalacin T Gel (clindamycin phosphate gel) as a therapeutic medication for acne vulgaris in acne vulgaris patients, including children ages 13 and up, in order to clarify the clinical positioning of Dalacin T Gel.</brief_summary>
	<brief_title>Dalacin-T Gel Post Approval Study</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Nadifloxacin</mesh_term>
	<criteria>Acne vulgaris patients found by a investigator to have at least 10 inflammatory lesions (papules, pustules) on a portion of either a cheeks or the forehead, with an inflammation severity of moderate or worse. Patients with, for example, acne elastosis, steroidal acne, necrotizing acne, or occupational acne.</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>